share_log

久光製薬:AMEDによるワクチン・新規モダリティ研究開発事業(一般公募)の公募採択のお知らせ

Hisamitsu Pharmaceutical: Notice of adoption of an open call for the vaccine/novel modality research and development project (public call) by AMED

JPX ·  Nov 18 14:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more